Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377) |
---|
02/14/2007 | CN1914218A Process for preparing asymmetric conversion reaction catalyst |
02/14/2007 | CN1914217A Metallocene-based chiral phosphine or arsine ligands |
02/14/2007 | CN1914216A Separation of nickel(0) complexes and phosphorus-containing ligands from nitrile mixtures |
02/14/2007 | CN1914215A Vanadium compounds as inhibitors of phosphatases |
02/14/2007 | CN1914206A 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments |
02/14/2007 | CN1911941A Preparation method of 2,10-dihydro-9-oxo-10-phospho hetero phenanthrene |
02/14/2007 | CN1911940A 2,2',6,6'-tetra substituted nitrogen phosphine ligand and its synthesis method |
02/14/2007 | CN1911939A Preparation method of phosphite ester kind antioxidant |
02/14/2007 | CN1911938A Imidazoline amophoteric surface active agent and its synthesis technology |
02/14/2007 | CN1300880C Supporting electrolyte for cell and method for production thereof, and cell |
02/14/2007 | CN1300157C Process to prepare multidentate phosphine compound |
02/14/2007 | CN1300156C Method for the separation of acids from chemical reaction mixtures by means of ionic fluids |
02/14/2007 | CN1300155C Clycerophosphoinositol derivatives as modulators of cytosolic phospholipase |
02/14/2007 | CN1300141C Process and intermediates for making non-nucleoside HIV-1 reverse transcriptase inhibitors |
02/13/2007 | US7176305 Overdrying 5'-guanylic acid disodium crystals, 5'-inosinic acid disodium crystals, and mixture containing the alcohol, contacting the mixture with hdrophilic organic solvent to control the humidity |
02/13/2007 | US7176252 Solid melt blended phosphite composites |
02/13/2007 | CA2265660C Process of production of 4-substituted-3-halogeno-1,4-benzoxazepine derivative and salts thereof |
02/13/2007 | CA2239618C Improved metal-ligand complex catalyzed processes |
02/13/2007 | CA2111397C Process for imparting oil-and water-repellency to the surface of porous ceramic materials |
02/13/2007 | CA2063249C Organic compounds of phosphorus complexed by boron |
02/08/2007 | WO2007016264A2 Method for enantioselective synthesis of phosphorus-stereogenic phosphines |
02/08/2007 | WO2007014846A1 Novel benzimidazole (thio) carbamates with antiparasitic activity and the synthesis thereof |
02/08/2007 | WO2007014524A1 Erianin salts, their preparation methods and pharmaceutical compositions containing the same |
02/08/2007 | WO2007014491A1 Acyclic nucleotide phosphonates and their use in antiviral agents |
02/08/2007 | US20070032455 Novel nitrophenyl mustard and nitrophenylaziridine alcohols and their corresponding phosphates and their use as targeted cytotoxic agents |
02/08/2007 | US20070032449 Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae infections |
02/08/2007 | US20070031729 Ionic liquids, electrolyte salts for electrical storage devices, liquid electrolytes for electrical storage devices, electrical double-layer capacitors, and secondary batteries |
02/08/2007 | US20070031481 Phospolipid derivative |
02/08/2007 | CA2616512A1 Novel benzimidazole (thio) carbamates with antiparasitic activity and the synthesis thereof |
02/07/2007 | EP1750127A1 Affinity particle and method of affinity separation |
02/07/2007 | EP1749513A1 Photopolymerisable dental material with bisacylphosphine oxides as inhibitors |
02/07/2007 | EP1749032A1 Alkoxyamines containing a radically polymerizable group |
02/07/2007 | EP0971748B1 Tetraaza- or n2s2- complexants, and their use in radiodiagnostics or radiotherapy |
02/07/2007 | CN1910230A Fire-retardancy styrene resin composition and its forming product |
02/07/2007 | CN1907992A Ruthenium complex compound ligand, ruthenium complex compound, solid carrying ruthenium complex catalyst and preparation method and use thereof |
02/07/2007 | CN1907990A Preparation method of 3,9-di[4-(1-methyl-1-benzoethyl)phenoxy]-2,4,8,10-tetraoxy-3,9-diphosphorspiro[5,5]hendecane |
02/07/2007 | CN1907989A Setoglaucine salt, preparation method thereof and medicinal composition containing the same |
02/07/2007 | CN1907288A No dump-agglomeration powder phospholipid and preparation process thereof |
02/07/2007 | CN1298726C Process for synthesis of melamine salt of pentaerythritol bis (dihydrogen phosphate) |
02/07/2007 | CN1298700C Pseudo-nervonic amide and cosmetics composition containing the same |
02/07/2007 | CN1298699C Method for preparing alkoxyamines from nitroxides |
02/07/2007 | CN1298698C Method of purifying quaternary alkylammonium salt and quaternary alkylammonium salt |
02/06/2007 | US7173138 two pnicogen-containing groups joined to via a xanthene-like or triptycene-like molecular skeleton; at least one pyrrole group is covalently bound via its nitrogen atom to each pnicogen atom form complexes with transition metals |
02/06/2007 | US7173130 Detection of transmembrane potentials by optical methods |
02/06/2007 | US7173039 Compounds that modulate or inhibit enzymes for occular diseases |
02/06/2007 | US7173032 Antiproliferative agents for smooth muscle cells; antiinflammatory agents for endothelial cells; restenosis, atherosclerosis |
02/06/2007 | US7173020 Anticancer agents and drug delivery agents with nucleotides |
02/06/2007 | US7173018 Antiinflammatory agents; antiischemic agents; antiarthritic agents; antihistamines; multiple sclerosis; Alzheimer's disease; Huntington's disease; parkinson's disease; antiepileptic agents; headaches |
02/06/2007 | US7172905 Polypeptide immobilization |
02/01/2007 | WO2007014326A1 Coumarin-based amino acids for use in enzyme activity and substrate specificity assays |
02/01/2007 | WO2007013759A1 Method of preparing phosphonium compound for cyclic olefin polymerization |
02/01/2007 | WO2007013190A1 Oligonucleotide probe |
02/01/2007 | WO2007013097A1 Improved process for the preparation of ibandronate sodium |
02/01/2007 | WO2007013086A1 Novel polymorphs of tenofovir disoproxil fumarate |
02/01/2007 | WO2007012655A1 Process for preparing optically active diphosphanes |
02/01/2007 | WO2007012100A1 Oxidised phospholipids comprising a fluorophore moiety and use in the determination of the presence of enzymes having antiatherogenetic activity |
02/01/2007 | WO2006012294A3 Chemical vapor deposition with nucleophilic stable carbene-containing precursors |
02/01/2007 | WO2004003005A3 Sh2 domain binding inhibitors |
02/01/2007 | US20070027323 Crystal structure; hydrates; dissolving in solution; adding base; cooling; crystallization; salt formation |
02/01/2007 | US20070027297 Modified polyethylenephosphinic acids and their salts |
02/01/2007 | US20070027277 Method of preparing phosphonium compound for cyclic olefin polymerization |
02/01/2007 | US20070027116 Therapeutic phosphonate derivatives |
02/01/2007 | US20070027115 Triazole derivatives useful in therapy |
02/01/2007 | US20070027114 cancer and/or viral infection, leukemia; improved pharmacological properties; oral bioavailability, greater potency, extended half-life in vivo, Side effects reduction; 2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-6-diethoxy-phosphoryl)-hexanoic acid, diethyl cyano phosphonate |
02/01/2007 | US20070027067 Transition-state Inhibitors of Pin1, alpha-Ketoamide-containing peptidomimetics, and synthesis thereof |
02/01/2007 | US20070027039 Low viscosity functional fluids |
02/01/2007 | US20070026384 Detection of transmembrane potentials by optical methods |
02/01/2007 | DE102005036340A1 Verfahren zur Herstellung optisch aktiver Bis-Phosphinylalkane A process for preparing optically active bisphosphinylalkanes |
02/01/2007 | CA2654743A1 Oxidised phospholipids comprising a fluorophore moiety and use in the determination of the presence of enzymes having antiatherogenetic activity |
02/01/2007 | CA2617065A1 Coumarin-based amino acids for use in enzyme activity and substrate specificity assays |
01/31/2007 | EP1747213A1 Novel 7,7-disubstituted derivatives of (5h,9h)-6,8-dioxabenzocycloheptene, preparation method thereof and use of same in the synthesis of non-steroidal vitamin d analogues |
01/31/2007 | EP1747205A1 Pharmaceutical compositions |
01/31/2007 | EP1345915B1 Improved process for the preparation of water-soluble o-phosphonooxymethyl prodrugs |
01/31/2007 | CN1906202A Method for asymmetric synthesis |
01/31/2007 | CN1903863A Preparation method of adefovir dipivoxil crystal |
01/31/2007 | CN1903862A Substituted methanoyl alkyl phosphonate ester kind optical active isomer possessing herbiciding activity and its preparation method |
01/31/2007 | CN1297562C Diphosphine |
01/31/2007 | CN1297561C Solvent-free method for preparing sterically hindered phosphoramidates |
01/31/2007 | CN1297560C Phosphonium phosphinate compounds and their preparation |
01/31/2007 | CN1297535C Method for producing perfluoroalkane sulfonic acid esters and the salts thereof |
01/31/2007 | CN1297266C Stabilized ascorbic acid derivatives |
01/30/2007 | US7169953 For use as catalysts in asymmetric reactions, such as, hydrogenation, hydride transfer, allylic alkylation, hydrosilylation, hydroboration, hydrovinylation, hydroformylation, olefin metathesis, hydrocarboxylation |
01/30/2007 | US7169879 Bisphenyl-2,3,5,6-tetrafluoro-4-trifluoromethylphenyl phosphine oxide derivative and synthesis thereof |
01/30/2007 | US7169818 Lysophosphatidic acid receptor agonists and antagonists |
01/30/2007 | US7169817 Treatment and/or prevention of diseases or disorders mediated by lymphocyte interactions. |
01/30/2007 | US7169785 e.g., 2-{[4-(Cyclohexylmethyl-amino)-6-(3-fluoro-4-methoxy-phenylamino)-[1,35]triazin-2-ylamino]-methyl}-cyclopentanone; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme |
01/30/2007 | US7169784 Medical devices employing triazine compounds and compositions thereof |
01/30/2007 | US7169742 Forming a textile finishing agent with superior clarity; discoloration inhibition |
01/30/2007 | CA2207628C 3-aryl-1,2,4-triazole derivatives with herbicidal properties |
01/25/2007 | WO2007011998A2 Diaryl alkylphosphonates and method for preparing same |
01/25/2007 | WO2007011658A1 Antiviral compounds |
01/25/2007 | WO2007011570A2 Low-phosphorous lubricant additive |
01/25/2007 | WO2007010556A1 Process for the production of 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof |
01/25/2007 | WO2007010016A2 Bisphosphines |
01/25/2007 | WO2006130353A3 Light-emitting device containing bis-phosphineoxide compound |
01/25/2007 | WO2006121861A3 Biphenylazetidinone cholesterol absorption inhibitors |
01/25/2007 | WO2006036881B1 Resorcinol carbonate-based phosphate ester compounds as flame retardants |
01/25/2007 | WO2006028982A3 Dinitrogen reduction |
01/25/2007 | US20070021626 Diaryl alkylphosphonates and methods for preparing same |
01/25/2007 | US20070021619 Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation |